You are logged out -> Log in

Bicycles of Hope: A Vital Social Responsibility

 

Link: https://cmc-terrasanta.org/en/media/terra-santa-news/18552/bicycles-of-hope:-a-vital-social-responsibility

From: Christian Media Center

Date: October 31, 2019

 

“An ounce of prevention is worth a pound of cure”. This is a true proverb, especially when talking about the spread of breast cancer in Arab society. Early detection saves a life. In this context, Diyar Academy for Children and Youth in Bethlehem, in cooperation with Bethlehem Municipality and Health Work Committees, organized on the 24th of October -the Breast Cancer Awareness Month-the Hope Bicycle Campaign, under the slogan “Do not exclude symptoms… test and rest assured.”.

JACQUELINE JAZRAWI
Director of Diyar Sports Club
"Today's event was about a vital social responsibility for our society. As girls in sport and active actors in our community, we thought of using bicycles as a tool loved by young, old, male, and female, to deliver a focused health message."

JACQUELINE JAZRAWI
Director of Diyar Sports Club
"Today, we applied the idea on the ground, to give hope to every woman, not only those with breast cancer but for every woman facing difficult circumstances. This campaign came to convey the message “where there is life, there is hope”. These bicycles will continue, God willing, to deliver the message of hope. We believe in the power, effects and positive impact of sport on society."

Professor Moen Kanaan, head of the Genetics Research Laboratory at Bethlehem University and the Arab Consultative Hospital, tells us about some of the tests used to detect breast cancer.

Prof. MOEN CANAAN
Head of Genetic Research Laboratory at Bethlehem University
"One of the tests we have in the lab is what we refer to as the BROCA test. It involves fifty-four genes including Broca 1, Broca 2, and 52 other genes in one test. Our goal is to determine whether the risk of breast cancer is inherited or acquired. This is done by examining the mutations and changes in these genes, and the way they appear. We will then be able to determine what administrative procedures and issues a breast cancer patient should go through."

Prof. MOEN CANAAN
Head of Genetics Research Laboratory at Bethlehem University
"In addition to breast cancer screening, we are developing or introducing a new test called Oncotype DX, which helps to understand the tumor itself. Then we look at the genetic determinants of cancer itself, based on which we can predict, whether the patient will benefit from chemotherapy or not and whether the patient will be exposed to cancer in the next ten years after diagnosis."

As for the challenges facing the study of causes of breast cancer, Prof. Canaan said

Prof. MOEN CANAAN
Head of Genetic Research Laboratory at Bethlehem University
"One of the problems facing cancer screening is that people tend to keep quiet about it, and we understand this. However, you should trust that sharing the risk of this disease with others who have it; disclosing the risks of inheriting it for the next generation; will help to cope with cancer psychologically; and enable people to express what they are already experiencing, adding significant asset to pain-relieving treatment; as well as the expected benefits of medication, and follow-up in the treatment of future disease."

Dear spectator:
“Do not exclude symptoms… test and rest assured.”

Bethlehem University Foundation
Email: brds@bufusa.org
Phone: +1-240-241-4381
Fax: +1-240-553-7691
Beltsville, MD USA
Bethlehem University in the Holy Land
E-mail: info@bethlehem.edu
Phone: +972-2-274-1241
Fax: +972-2-274-4440
Bethlehem, Palestine